Metabolic syndrome and benign prostatic enlargement: a systematic review and meta‐analysis

@article{Gacci2015MetabolicSA,
  title={Metabolic syndrome and benign prostatic enlargement: a systematic review and meta‐analysis},
  author={Mauro Gacci and Giovanni Corona and Linda Vignozzi and Matteo Salvi and Sergio Serni and Cosimo De Nunzio and Andrea Tubaro and Matthias Oelke and Marco Carini and Mario Maggi},
  journal={BJU International},
  year={2015},
  volume={115}
}
To summarise and meta‐analyse current literature on metabolic syndrome (MetS) and benign prostatic enlargement (BPE), focusing on all the components of MetS and their relationship with prostate volume, transitional zone volume, prostate‐specific antigen and urinary symptoms, as evidence suggests an association between MetS and lower urinary tract symptoms (LUTS) due to BPE. 

Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study)

To investigate the association between metabolic syndrome (MetS) and morphological features of benign prostatic enlargement (BPE), including total prostate volume (TPV), transitional zone volume

Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross‐sectional, UK epidemiological study

To compare the prevalence of metabolic syndrome and the components of metabolic syndrome in men aged ≥50 years with and without clinical benign prostatic hyperplasia (BPH).

Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study

To evaluate the impact of components of metabolic syndrome (MetS) on urinary outcomes after surgery for severe lower urinary tract symptoms (LUTS) due to benign prostatic enlargement (BPE), as

The impacts of metabolic syndrome and lifestyle on the prevalence of benign prostatic hyperplasia requiring treatment: historical cohort study of 130 454 men

TLDR
To investigate the influences of lifestyle and metabolic syndrome on the prevalence of benign prostatic hyperplasia (BPH) requiring treatment using a large historical cohort, a large Historical cohort of patients is used.

The association between metabolic syndrome and benign prostatic hyperplasia: a systematic review and meta-analysis

TLDR
The study suggested that MetS may be one of the risk factors for the clinical progress of BPH, however, further study is warranted to support these results.

Effects of metabolic syndrome on benign prostatic hyperplasia

Pathophysiology of benign prostate enlargement and lower urinary tract symptoms: Current concepts

TLDR
Current concepts in the epidemiology, etiology, and pathophysiology of BPE/BPH and male LUTS are reviewed.

Connections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis

  • G. RussoT. Castelli G. Morgia
  • Medicine
    The aging male : the official journal of the International Society for the Study of the Aging Male
  • 2015
TLDR
The association between MetS and LUTS/BPE remain unclear and further observational studies in a population with metabolic disorders should be conducted in order to address it's potential role in determining LUTs/B PE.

The Association Between Metabolic Syndrome and Characteristics of Benign Prostatic Hyperplasia

TLDR
The results of this meta-analysis are consistent with literature indicating that BPH patients with MS have a higher prostate growth rate and larger prostate volume than those without MS; however, further study is necessary to determine the association of BPH and metabolic disorder elements and the potential risk of disease progression in BPH Patients with MS.

Association between metabolic syndrome and severity of lower urinary tract symptoms (LUTS): an observational study in a 4666 European men cohort

TLDR
To evaluate the relationship between metabolic syndrome and the frequency and severity of lower urinary tract symptoms (LUTS), a large number of patients with metabolic syndrome are diagnosed with LUTS.
...

References

SHOWING 1-10 OF 56 REFERENCES

The association between metabolic syndrome and prostate‐specific antigen levels

TLDR
The aim of this study was to examine whether PSA levels were affected by MS, a common metabolic disorder related to the increasing prevalence of obesity.

Lower urinary tract symptoms, obesity and the metabolic syndrome

TLDR
New data points to a strong relationship between metabolic syndrome and BPH/LUTS, indicating a common cause, and further exploration of this relationship may result in a new understanding of the pathophysiology, treatment, and prevention of these disorders.

Central Obesity as a Risk Factor for Prostatic Hyperplasia

TLDR
The impact of obesity on prostate volume in men without overt obesity‐related metabolic diseases is examined to find out whether these diseases influence prostatic hyperplasia.

[Correlation between metabolic syndrome and clinical progression in patients with benign prostatic hyperplasia].

TLDR
Metabolic syndrome affects the clinical progression in patients with BPH and clinical attention should be paid, according to whether or not there was a diagnosis of metabolic syndrome.

Metabolic syndrome and lower urinary tract symptoms: the role of inflammation

TLDR
The significantly positive association between MetS and prostatic AP diameter could support the observation that MetS patients presented lower uroflowmetric parameters and can be regarded as a new determinant of prostate inflammation and BPH progression.
...